Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies
- PMID: 15451924
- DOI: 10.2337/diacare.27.10.2495
Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies
Erratum in
- Diabetes Care. 2004 Dec;27(12):3032
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
